These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21951953)

  • 1. CAMTA1 T polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease.
    Miller LA; Gunstad J; Spitznagel MB; McCaffery J; McGeary J; Poppas A; Paul RH; Sweet LH; Cohen RA
    Psychogeriatrics; 2011 Sep; 11(3):135-40. PubMed ID: 21951953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCF7L2 polymorphism and cognitive test performance in cardiovascular disease.
    Keary TA; Gunstad J; Benitez A; Spitznagel MB; McCaffery J; McGeary JE; Poppas A; Paul RH; Sweet LH; Cohen RA
    Psychogeriatrics; 2012 Jun; 12(2):93-8. PubMed ID: 22712642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
    Szabo AJ; Alosco ML; Miller LA; McGeary JE; Poppas A; Cohen RA; Gunstad J
    Psychogeriatrics; 2013 Dec; 13(4):206-12. PubMed ID: 24289461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced memory in fat mass and obesity-associated allele carriers among older adults with cardiovascular disease.
    Alosco ML; Benitez A; Gunstad J; Spitznagel MB; McCaffery JM; McGeary JE; Poppas A; Paul RH; Sweet LH; Cohen RA
    Psychogeriatrics; 2013 Mar; 13(1):35-40. PubMed ID: 23551410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
    Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
    Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and memory in the sixth decade of life.
    Schultz MR; Lyons MJ; Franz CE; Grant MD; Boake C; Jacobson KC; Xian H; Schellenberg GD; Eisen SA; Kremen WS
    Neurology; 2008 May; 70(19 Pt 2):1771-7. PubMed ID: 18235080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease.
    Gunstad J; Benitez A; Hoth KF; Spitznagel MB; McCaffery J; McGeary J; Kakos LS; Poppas A; Paul RH; Jefferson AL; Sweet LH; Cohen RA
    Stroke; 2009 Sep; 40(9):2969-72. PubMed ID: 19590054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus.
    Oroszi G; Lapteva L; Davis E; Yarboro CH; Weickert T; Roebuck-Spencer T; Bleiberg J; Rosenstein D; Pao M; Lipsky PE; Goldman D; Lipsky RH; Illei GG
    Ann Rheum Dis; 2006 Oct; 65(10):1330-5. PubMed ID: 16606648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.
    Greenbaum L; Springer RR; Lutz MW; Heymann A; Lubitz I; Cooper I; Kravitz E; Sano M; Roses AD; Silverman JM; Saunders AM; Beeri MS
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1492-9. PubMed ID: 25044051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin genotype modulates the relationships of glycaemic control with cognitive function in elderly individuals with type 2 diabetes.
    Guerrero-Berroa E; Ravona-Springer R; Heymann A; Schmeidler J; Levy A; Leroith D; Beeri MS
    Diabetologia; 2015 Apr; 58(4):736-44. PubMed ID: 25628235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.
    Dore GA; Elias MF; Robbins MA; Elias PK; Nagy Z
    Diabetologia; 2009 Dec; 52(12):2551-60. PubMed ID: 19693485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
    Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
    Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities.
    Bartrés-Faz D; Junqué C; López-Alomar A; Valveny N; Moral P; Casamayor R; Salido A; Bel C; Clemente IC
    J Am Geriatr Soc; 2001 Jul; 49(7):985-90. PubMed ID: 11527492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological function in nondemented carriers of presenilin-1 mutations.
    Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Chavez M; Fairbanks L; Paz F; Varpetian A; Maldonado HC; Macias-Islas MA; Murrell J; Ghetti B; Kawas C
    Neurology; 2005 Aug; 65(4):552-8. PubMed ID: 16116115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang M-; Rosado L; Orbe Reilly M; Ruiz D; Ross B; Verbitsky M; Kisselev S; Louis E; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Andrews H; Waters C; Fahn S; Cote L; Frucht S; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Siderowf A; Payami H; Molho E; Factor S; Ottman R; Clark LN; Marder K
    Neurology; 2012 May; 78(18):1434-40. PubMed ID: 22442429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly.
    Kölsch H; Wagner M; Bilkei-Gorzó A; Toliat MR; Pentzek M; Fuchs A; Kaduszkiewicz H; van den Bussche H; Riedel-Heller SG; Angermeyer MC; Weyerer S; Werle J; Bickel H; Mösch E; Wiese B; Daerr M; Jessen F; Maier W; Dichgans M
    J Neural Transm (Vienna); 2009 Jul; 116(7):897-903. PubMed ID: 19468819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
    Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
    Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.